Recent Publications:
1) Oniciu,
D. C.; Pop, E.; Dasseux, J.-L. H.; Mueller, R.; Yang, J.; Bell, R. P. L.; Regeling, H.;
Ebbers, E. J.; Leemhuis, F. M. C.; Cramer, C. T.; Goetz, B.; Pape, M. E.; Bisgaier, C. L. Long hydrocarbon chain diols and diacids with central
ether or ketone moieties that favorably alter lipid disorders. Pharmazie 2006,
61, 157-165.
2) Oniciu,
D. C.; Bell, R. P. L.; McCosar, B. H.; Bisgaier, C. L.; Dasseux, J.-L. H.; Verdijk, D.;
Relou, M.; Smith, D.; Regeling, H.; Leemhuis, F. M. C.; Ebbers, E. J.; Mueller, R.; Zhang,
L.; Pop, E.; Cramer, C. T.; Goetz, B.; McKee, A.; Pape, M. E.; Krause, B. R. Syntheses of Pantolactone and Pantothenic Acid
Derivatives as Potential Lipid Regulating Agents. Synth.
Commun. 2006, 36, 365-391.
3) Oniciu, D. C.; Dasseux, J.-L. H.; Yang, J.; Mueller, R.; Pop, E.;
Denysenko, A.; Duan, C.; Huang, T.-B.; Zhang, L.; Krause, B. R.; Drake, S. L.; Lalwani,
N.; Cramer, C. T.; Goetz, B.; Pape, M. E.; McKee, A.; Fici, G. J.; Lutostanski, J. M.;
Brown, S. C.; Bisgaier, C. L. Influence of Various Central Moieties on the Hypolipidemic Properties of
Long Hydrocarbon Chain Diols and Diacids. J. Med. Chem. 2006, 49,
334-348.
4) Yang, J.;
Mueller, R.; Pop, E.; Dasseux, J.-L. H.; Oniciu; D. C. Kilogram-Scale Synthesis of
Bis(6-hydroxy-5,5-dimethylhexyl)ether (ESP24232), a Novel Lipid Lowering Agent. Org.
Prep. Proc. Int. 2004, 36, 587-596.
5) Mueller,
R.; Yang, J.; Duan, C.; Pop, E.; Geoffroy, O. J.; Zhang, L. H.; Huang, T.-B.; Denisenko,
S.; McCosar, B. H.; Oniciu, D. C.; Bisgaier, C. L.; Pape, M. E.; Freiman, C. D.; Goetz,
B.; Cramer, C. T.; Hopson, K. L.; Dasseux, J.-L. H. Long Hydrocarbon Chain Keto Diols and
Diacids that Favorably Alter Disorders In Vivo. J. Med. Chem. 2004, 47,
6082-6099.
6) Mueller,
R.; Yang, J.; Duan, C.; Pop, E.; Zhang, L. H.; Huang, T.-B.; Denysenko, A.; Denisko, O.
V.; Oniciu, D. C.; Bisgaier, C. L.; Pape, M. E.; Freiman, C. D.; Goetz, B.; Cramer, C. T.;
Hopson, K. L.; Dasseux, J.-L. H. Long Hydrocarbon Chain Ether Diols and Ether Diacids that
Favorably Alter Lipid Disorders In Vivo. J. Med. Chem. 2004, 47,
5183-5197.
7) Bergeron, R. J.;
Mueller, R.; McManis, J. S.; Yao, G. W.; Huang, G. An Improved Synthesis of (3S,12S)-N1,N14-Diethyl-3,12-dihydroxyhomospermine,
a Polyamine Analogue Therapeutic Agent. Synthesis 2001, 1043-1048.
8) Bergeron,
R. J.; Mueller, R.; Bussenius, J.; McManis, J. S.; Merriman, R. L.; Smith, R.E.; Yao, H.;
Weimar, W. R. Synthesis and Evaluation of Hydroxylated Polyamine Analogues as
Antiproliferatives. J. Med. Chem. 2000, 43, 224-235.
9) Bergeron,
R. J.; Bussenius, J.; Mueller, R.; McCosar, B. H.; McManis, J. S. (R)- and (S)-N-(Benzyloxycarbonyl)-3,4-epoxybutylamine.
New 4-amino-2-hydroxybutyl synthons for the synthesis of the hypusine reagents and (R)-6-
and (S)-7-hydroxyspermidine. Tetrahedron: Asymmetry 1999, 10,
4285-4294.
10) Bergeron, R. J.; Weimar, W.
R.; Mueller, R.; Zimmerman, C. O.; McCosar, B. H.; Yao, H.; Smith, R. E. Synthesis of
Reagents for the Construction of Hypusine and Deoxyhypusine Peptides and Their Application
as Peptidic Antigens. J. Med. Chem. 1998, 41, 3888-3900.
11) Bergeron, R. J.; Weimar, W.
R.; Mueller, R.; Zimmerman, C. O.; McCosar, B. H.; Yao, H.; Smith, R. E. Effect of
Polyamine Analogues on Hypusine Content in JURKAT T-Cells. J. Med. Chem. 1998,
41, 3901-3908.
12) Bergeron, R. J.; Ludin, C.;
Mueller, R.; Smith, R. E.; Phanstiel, IV, O. Development of a Hypusine Reagent for Peptide
Synthesis. J. Org. Chem. 1997, 62, 3285-3290. |